Egyesült Államok - angol - NLM (National Library of Medicine)

akorn - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Egyesült Államok - angol - NLM (National Library of Medicine)

teva pharmaceuticals, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Egyesült Államok - angol - NLM (National Library of Medicine)

qilu pharmaceutical co., ltd. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Egyesült Államok - angol - NLM (National Library of Medicine)

apotex corp. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate for injection is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Egyesült Államok - angol - NLM (National Library of Medicine)

emd serono, inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix 0.25 mg in 1 ml - cetrotide® (cetrorelix acetate for injection) is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrotide® (cetrorelix acetate for injection) is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions). - severe renal impairment

Egyesült Államok - angol - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - cetrorelix acetate (unii: w9y8l7gp4c) (cetrorelix - unii:oon1hfz4ba) - cetrorelix acetate for injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation. cetrorelix acetate is contraindicated under the following conditions: - hypersensitivity to cetrorelix acetate, extrinsic peptide hormones or mannitol. - known hypersensitivity to gnrh or any other gnrh analogs. - known or suspected pregnancy, and lactation (see precautions ). - severe renal impairment

Szingapúr - angol - HSA (Health Sciences Authority)

merck pte. ltd. - cetrorelix (as cetrorelix acetate) - injection - 0.25 mg - cetrorelix (as cetrorelix acetate) 0.25 mg

Kanada - angol - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 0.25mg - cetrorelix (cetrorelix acetate) 0.25mg - gonadotropin-releasing hormone antagonists

Kanada - angol - Health Canada

emd serono, a division of emd inc., canada - cetrorelix (cetrorelix acetate) - powder for solution - 3mg - cetrorelix (cetrorelix acetate) 3mg - gonadotropin-releasing hormone antagonists

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - cetrorelix, quantity: 0.25 mg - injection, powder for - excipient ingredients: mannitol - indications: prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques. in clinical trials cetrotide was used with human menopausal gonadotrophin (hmg), however limited experience with recombinant fsh suggested similar efficacy.